FDA: Medical Device Makers Urged To Secure Post Market Devices from Cyber Attack

The FDA issued non-binding postmarket guidance urging medical device manufacturers to implement comprehensive cybersecurity risk management programs, prioritize vulnerabilities that could enable unauthorized access or misuse, adopt coordinated vulnerability disclosure practices, and participate in information-sharing organizations to improve detection and remediation of security issues in deployed medical devices.